Sector ratings ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/09/2024 BST			5-day change	1st Jan Change
298.70 ^USD	-1.26%		-7.25%	+5.52%

08-14	ICON Names Nigel Clerkin as CFO	DJ
08-14	ICON Appoints New Chief Financial Officer	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG Refinitiv	Capi. ($)
ICON PUBLIC LIMITED COMPANY		B-	24.74B
LONZA GROUP AG		A	46.26B
IQVIA HOLDINGS INC.		B	43.91B
ALNYLAM PHARMACEUTICALS, INC.	-	B	32.5B
CELLTRION, INC.		C	29.51B
MODERNA, INC.	-	B-	29.45B
UNITED THERAPEUTICS CORPORATION		B+	15.51B
BIO-TECHNE CORPORATION		B+	11.43B
MEDPACE HOLDINGS, INC.		C+	10.5B
QIAGEN N.V.		A	10.2B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		C+	9.71B
IONIS PHARMACEUTICALS, INC.	-	B+	7.07B
REVOLUTION MEDICINES, INC.	-	C-	7.04B
BACHEM HOLDING AG		B-	6.78B
HANGZHOU TIGERMED CONSULTING CO., LTD		B+	5.54B
BLUEPRINT MEDICINES CORPORATION		B-	5.48B
PHARMARON BEIJING CO., LTD.		B+	4.54B
Average		B	17.66B
Weighted average by Cap.		B